-
1
-
-
37349107479
-
Toward the harmonization of immune monitoring in clinical trials: Quo vadis?
-
(PMID: 17721782)
-
Britten CM, Janetzki S, van der Burg SH, Gouttefangeas C, Hoos A. Toward the harmonization of immune monitoring in clinical trials: quo vadis? Cancer Immunol Immunother 2008; 57: 285-288. (PMID: 17721782)
-
(2008)
Cancer Immunol Immunother
, vol.57
, pp. 285-288
-
-
Britten, C.M.1
Janetzki, S.2
van der Burg, S.H.3
Gouttefangeas, C.4
Hoos, A.5
-
2
-
-
70349833381
-
"MIATA"-minimal information about T cell assays
-
(PMID: 19833080)
-
Janetzki S, Britten CM, Kalos M, Levitsky HI, Maecker HT, Melief CJM, Old LJ, Romero P, Hoos A, Davis MM. "MIATA"-minimal information about T cell assays. Immunity 2009; 31: 527-528. (PMID: 19833080)
-
(2009)
Immunity
, vol.31
, pp. 527-528
-
-
Janetzki, S.1
Britten, C.M.2
Kalos, M.3
Levitsky, H.I.4
Maecker, H.T.5
Melief, C.J.M.6
Old, L.J.7
Romero, P.8
Hoos, A.9
Davis, M.M.10
-
3
-
-
37349020262
-
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
-
Elispot Proficiency Panel of the CVC Immune Assay Working Group, (PMID: 17721781)
-
Janetzki S, Panageas KS, Ben-Porat L, Boyer J, Britten CM, Clay TM, Kalos M, Maecker HT, Romero P, Yuan J, Kast WM, Hoos A, Elispot Proficiency Panel of the CVC Immune Assay Working Group. Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI). Cancer Immunol Immunother 2008; 57: 303-315. (PMID: 17721781)
-
(2008)
Cancer Immunol Immunother
, vol.57
, pp. 303-315
-
-
Janetzki, S.1
Panageas, K.S.2
Ben-Porat, L.3
Boyer, J.4
Britten, C.M.5
Clay, T.M.6
Kalos, M.7
Maecker, H.T.8
Romero, P.9
Yuan, J.10
Kast, W.M.11
Hoos, A.12
-
4
-
-
37349077911
-
The CIMT-monitoring panel: A two-step approach to harmonize the enumeration of anti-gen-specific CD8+ T lymphocytes by structural and functional assays
-
(PMID: 17721783)
-
Britten CM, Gouttefangeas C, Welters MJ, Pawelec G, Koch S, Ottensmeier C, Mander A, Walter S, Paschen A, Müller-Berghaus J, Haas I, Mackensen A, Køllgaard T, thor Straten P, Schmitt M, Gian-nopoulos K, Maier R, Veelken H, Bertinetti C, Konur A, Huber C, Stevanovic S, Wölfel T, van der Burg SH. The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of anti-gen-specific CD8+ T lymphocytes by structural and functional assays. Cancer Immunol Immunother 2008; 57: 289-302. (PMID: 17721783)
-
(2008)
Cancer Immunol Immunother
, vol.57
, pp. 289-302
-
-
Britten, C.M.1
Gouttefangeas, C.2
Welters, M.J.3
Pawelec, G.4
Koch, S.5
Ottensmeier, C.6
Mander, A.7
Walter, S.8
Paschen, A.9
Müller-Berghaus, J.10
Haas, I.11
Mackensen, A.12
Køllgaard, T.13
thor Straten, P.14
Schmitt, M.15
Gian-nopoulos, K.16
Maier, R.17
Veelken, H.18
Bertinetti, C.19
Konur, A.20
Huber, C.21
Stevanovic, S.22
Wölfel, T.23
van der Burg, S.H.24
more..
-
5
-
-
68549133403
-
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium
-
HLA-peptide Multi-mer Proficiency Panel of the CVC-CRI Immune Assay Working Group, (PMID: 19259668)
-
Britten CM, Janetzki S, Ben-Porat L, Clay TM, Kalos M, Maecker H, Odunsi K, Pride M, Old L, Hoos A, Romero P, HLA-peptide Multi-mer Proficiency Panel of the CVC-CRI Immune Assay Working Group. Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium. Cancer Immunol Immunother 2009; 58: 1701-1713. (PMID: 19259668)
-
(2009)
Cancer Immunol Immunother
, vol.58
, pp. 1701-1713
-
-
Britten, C.M.1
Janetzki, S.2
Ben-Porat, L.3
Clay, T.M.4
Kalos, M.5
Maecker, H.6
Odunsi, K.7
Pride, M.8
Old, L.9
Hoos, A.10
Romero, P.11
-
6
-
-
79960033714
-
A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining proto-cols
-
CRI-CIC Assay Working Group, (PMID: 21745365)
-
Attig S, Price L, Janetzki S, Kalos M, Pride M, McNeil L, Clay T, Yuan J, Odunsi K, Hoos A, Romero P, Britten CM, CRI-CIC Assay Working Group. A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining proto-cols. J Transl Med 2011; 9: 108. (PMID: 21745365)
-
(2011)
J Transl Med
, vol.9
, pp. 108
-
-
Attig, S.1
Price, L.2
Janetzki, S.3
Kalos, M.4
Pride, M.5
McNeil, L.6
Clay, T.7
Yuan, J.8
Odunsi, K.9
Hoos, A.10
Romero, P.11
Britten, C.M.12
-
7
-
-
80555129200
-
The impact of harmonization on ELISPOT assay performance
-
(PMID: 21956498)
-
Janetzki S, Britten CM. The impact of harmonization on ELISPOT assay performance. Methods Mol Biol 2012; 792: 25-36. (PMID: 21956498)
-
(2012)
Methods Mol Biol
, vol.792
, pp. 25-36
-
-
Janetzki, S.1
Britten, C.M.2
-
8
-
-
45749118607
-
Promoting coherent minimum reporting guidelines for biological and biomedical inves-tigations: The MIBBI project
-
(PMID: 18688244)
-
Taylor CF, Field D, Sansone S-A, Aerts J, Apweiler R, Ashburner M, Ball CA, Binz PA, Bogue M, Booth T, Brazma A, Brinkman RR, Michael Clark A, Deutsch EW, Fiehn O, Fostel J, Ghazal P, Gibson F, Gray T, Grimes G, Hancock JM, Hardy NW, Hermjakob H, Julian RK Jr, Kane M, Kettner C, Kinsinger C, Kolker E, Kuiper M, Le Novère N, Leebens-Mack J, Lewis SE, Lord P, Mallon AM, Mar-thandan N, Masuya H, McNally R, Mehrle A, Morrison N, Orchard S, Quackenbush J, Reecy JM, Robertson DG, Rocca-Serra P, Rodri-guez H, Rosenfelder H, Santoyo-Lopez J, Scheuermann RH, Schober D, Smith B, Snape J, Stoeckert CJ Jr, Tipton K, Sterk P, Untergasser A, Vandesompele J, Wiemann S. Promoting coherent minimum reporting guidelines for biological and biomedical inves-tigations: the MIBBI project. Nat Biotechnol 2008; 26: 889-896. (PMID: 18688244)
-
(2008)
Nat Biotechnol
, vol.26
, pp. 889-896
-
-
Taylor, C.F.1
Field, D.2
Sansone, S.-A.3
Aerts, J.4
Apweiler, R.5
Ashburner, M.6
Ball, C.A.7
Binz, P.A.8
Bogue, M.9
Booth, T.10
Brazma, A.11
Brinkman, R.R.12
Michael Clark, A.13
Deutsch, E.W.14
Fiehn, O.15
Fostel, J.16
Ghazal, P.17
Gibson, F.18
Gray, T.19
Grimes, G.20
Hancock, J.M.21
Hardy, N.W.22
Hermjakob, H.23
Julian Jr., R.K.24
Kane, M.25
Kettner, C.26
Kinsinger, C.27
Kolker, E.28
Kuiper, M.29
Le Novère, N.30
Leebens-Mack, J.31
Lewis, S.E.32
Lord, P.33
Mallon, A.M.34
Mar-thandan, N.35
Masuya, H.36
McNally, R.37
Mehrle, A.38
Morrison, N.39
Orchard, S.40
Quackenbush, J.41
Reecy, J.M.42
Robertson, D.G.43
Rocca-Serra, P.44
Rodri-guez, H.45
Rosenfelder, H.46
Santoyo-Lopez, J.47
Scheuermann, R.H.48
Schober, D.49
Smith, B.50
Snape, J.51
Stoeckert Jr., C.J.52
Tipton, K.53
Sterk, P.54
Untergasser, A.55
Vandesompele, J.56
Wiemann, S.57
more..
-
9
-
-
84880147841
-
-
Accessed from
-
MIATA compliant publications. Accessed from: http://miatapro-ject.org/index.php?option=com_content&view=arti-cle&id=133&Itemid=28
-
MIATA compliant publications.
-
-
-
10
-
-
79953750263
-
Mini-mal information about T cell assays (MIATA): The process of reach-ing the community of T cell immunologists in cancer and beyond
-
(PMID: 21080166)
-
Britten CM, Janetzki S, Van der Burg SH, Huber C, Kalos M, Lev-itsky HI, Maecker HT, Melief CJ, O'Donnell-Tormey J, Odunsi K, Old LJ, Pawelec G, Roep BO, Romero P, Hoos A, Davis MM. Mini-mal information about T cell assays (MIATA): the process of reach-ing the community of T cell immunologists in cancer and beyond. Cancer Immunol Immunother 2011; 60: 15-22. (PMID: 21080166)
-
(2011)
Cancer Immunol Immunother
, vol.60
, pp. 15-22
-
-
Britten, C.M.1
Janetzki, S.2
Van der Burg, S.H.3
Huber, C.4
Kalos, M.5
Lev-itsky, H.I.6
Maecker, H.T.7
Melief, C.J.8
O'Donnell-Tormey, J.9
Odunsi, K.10
Old, L.J.11
Pawelec, G.12
Roep, B.O.13
Romero, P.14
Hoos, A.15
Davis, M.M.16
-
11
-
-
84880168322
-
-
Accessed from
-
The MIATA Project. Accessed from: http://miataproject.org/
-
The MIATA Project.
-
-
-
12
-
-
84864325057
-
T cell assays and MIATA: The essential mini-mum for maximum impact
-
(PMID: 22840835)
-
Britten CM, Janetzki S, Butterfield LH, Ferrari G, Gouttefangeas C, Huber C, Kalos M, Levitsky HI, Maecker HT, Melief CJ, O'Donnell-Tormey J, Odunsi K, Old LJ, Ottenhoff TH, Ottensmeier C, Pawelec G, Roederer M, Roep BO, Romero P, van der Burg SH, Walter S, Hoos A, Davis MM. T cell assays and MIATA: the essential mini-mum for maximum impact. Immunity 2012; 37: 1-2. (PMID: 22840835)
-
(2012)
Immunity
, vol.37
, pp. 1-2
-
-
Britten, C.M.1
Janetzki, S.2
Butterfield, L.H.3
Ferrari, G.4
Gouttefangeas, C.5
Huber, C.6
Kalos, M.7
Levitsky, H.I.8
Maecker, H.T.9
Melief, C.J.10
O'Donnell-Tormey, J.11
Odunsi, K.12
Old, L.J.13
Ottenhoff, T.H.14
Ottensmeier, C.15
Pawelec, G.16
Roederer, M.17
Roep, B.O.18
Romero, P.19
van der Burg, S.H.20
Walter, S.21
Hoos, A.22
Davis, M.M.23
more..
-
13
-
-
80051775476
-
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leuke-mia
-
(PMID: 21832238)
-
Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, June CH. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leuke-mia. Sci Transl Med 2011; 3: 95ra73. (PMID: 21832238)
-
(2011)
Sci Transl Med
, vol.3
-
-
Kalos, M.1
Levine, B.L.2
Porter, D.L.3
Katz, S.4
Grupp, S.A.5
Bagg, A.6
June, C.H.7
-
14
-
-
84870976762
-
The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools
-
(PMID: 22491788)
-
Singh SK, Meyering M, Ramwadhdoebe TH, Stynenbosch LF, Redeker A, Kuppen PJ, Melief CJ, Welters MJ, van der Burg SH. The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools. Cancer Immunol Immunother 2012; 61: 1953-1963. (PMID: 22491788)
-
(2012)
Cancer Immunol Immunother
, vol.61
, pp. 1953-1963
-
-
Singh, S.K.1
Meyering, M.2
Ramwadhdoebe, T.H.3
Stynenbosch, L.F.4
Redeker, A.5
Kuppen, P.J.6
Melief, C.J.7
Welters, M.J.8
van der Burg, S.H.9
-
15
-
-
84871011037
-
DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8(+) T-cell responses and increases PSA dou-bling time
-
(PMID: 22729556)
-
Chudley L, McCann K, Mander A, Tjelle T, Campos-Perez J, Godeseth R, Creak A, Dobbyn J, Johnson B, Bass P, Heath C, Kerr P, Mathiesen I, Dearnaley D, Stevenson F, Ottensmeier C. DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8(+) T-cell responses and increases PSA dou-bling time. Cancer Immunol Immunother 2012; 61: 2161-2170. (PMID: 22729556)
-
(2012)
Cancer Immunol Immunother
, vol.61
, pp. 2161-2170
-
-
Chudley, L.1
McCann, K.2
Mander, A.3
Tjelle, T.4
Campos-Perez, J.5
Godeseth, R.6
Creak, A.7
Dobbyn, J.8
Johnson, B.9
Bass, P.10
Heath, C.11
Kerr, P.12
Mathiesen, I.13
Dearnaley, D.14
Stevenson, F.15
Ottensmeier, C.16
-
16
-
-
84880149425
-
-
Accessed from
-
MIATA checklist. Accessed from: http://www.miataproject.org/checklist.pdf
-
MIATA checklist.
-
-
-
17
-
-
81055146762
-
Harmoniza-tion of immune biomarker assays for clinical studies
-
(PMID: 22072636)
-
van der Burg SH, Kalos M, Gouttefangeas C, Janetzki S, Ottens-meier C, Welters MJ, Romero P, Britten CM, Hoos A. Harmoniza-tion of immune biomarker assays for clinical studies. Sci Transl Med 2011; 3: 108ps44. (PMID: 22072636)
-
(2011)
Sci Transl Med
, vol.3
-
-
van der Burg, S.H.1
Kalos, M.2
Gouttefangeas, C.3
Janetzki, S.4
Ottens-meier, C.5
Welters, M.J.6
Romero, P.7
Britten, C.M.8
Hoos, A.9
-
18
-
-
80054746895
-
A method-ological framework to enhance the clinical success of cancer immu-notherapy
-
(PMID: 21997622)
-
Hoos A, Britten CM, Huber C, O'Donnell-Tormey J. A method-ological framework to enhance the clinical success of cancer immu-notherapy. Nat Biotechnol 2011; 29: 867-870. (PMID: 21997622)
-
(2011)
Nat Biotechnol
, vol.29
, pp. 867-870
-
-
Hoos, A.1
Britten, C.M.2
Huber, C.3
O'Donnell-Tormey, J.4
|